K-numberK251276
Device nameSwoop® Portable MR Imaging® System
ApplicantHyperfine, Inc.
Product codeLNH
Device classClass II
Decision dateMay 21, 2025
DecisionSubstantially Equivalent
Regulation892.1000
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Swoop Portable MR Imaging System is a portable, ultra-low field magnetic resonance imaging device that produces images of the internal head structures in situations where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide diagnostic information useful in determining patient diagnosis.

Technological characteristics

The subject device has identical physical specifications to the predicate (835×630×652 mm, 320 kg, 63.3 mT permanent magnet, identical gradient strength and rise times). The main differences are software modifications related to pulse sequences and image processing, including an advanced reconstruction algorithm using deep learning to improve image quality for T1W, T2W, FLAIR, and DWI sequences, plus advanced interpolation capabilities in post-processing.

Test standards cited

IEC 62304:2016, NEMA MS 1/3/9/12-2008/2016, ISO 10993-1/5/10:2018/2009/2010, ISO 17664:2017, ASTM F3208-17, ANSI/AAMI ES 60601-1:2005/(R)2012, IEC 60601-1-2:2014, IEC 60601-1-6:2013, FDA Guidance on Device Software Functions and Cybersecurity, American College of Radiology standards for named sequences.

Substantial equivalence argument

The subject device shares identical intended use, patient population, anatomical site, operating principles, and hardware specifications with the predicate (K240944). The only modifications are software-based improvements to pulse sequences and image processing algorithms. Risk-based assessment determined these changes do not introduce new worst-case scenarios; extensive performance testing (image quality, contrast-to-noise ratio, radiologist validation) demonstrated Advanced Reconstruction maintains diagnostic consistency while improving image quality, and does not unexpectedly modify or remove pathology features compared to Linear Reconstruction baseline.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →